Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.01 billion.
Market Cap
1.12T
Revenue
110.01B
Profits
-41.27B
PE Ratio
n/a
Profit Margin
-37.51%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.64B | 0.32% | 865,853 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 64.57B | -0.67% | 889,901 | 14.92B |
| 3 | ARGX | argenx SE | 50.16B | 0.24% | 167,907 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.45B | -0.66% | 649,732 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.62B | -2.52% | 206,193 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.93B | 2.20% | 2,393,479 | - |
| 7 | RPRX | Royalty Pharma plc | 31.01B | -1.17% | 2,758,477 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.60B | 2.48% | 2,273,665 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.33B | 0.12% | 587,706 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.34B | -0.98% | 7,294,256 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.40B | -0.06% | 1,176,044 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.66B | 0.32% | 3,997,619 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.56B | 0.07% | 1,020,510 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.90B | -1.01% | 660,156 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.89B | -3.00% | 727,685 | 998.25M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.27B | -2.01% | 2,422,752 | 579.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 13.19B | 2.29% | 5,260,080 | - |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.57B | 0.67% | 1,279,225 | 1.06B |
| 19 | EXEL | Exelixis, Inc. | 12.56B | -0.34% | 2,104,267 | 2.38B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.09B | 1.36% | 330,935 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 12.05B | -0.75% | 646,605 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.08B | 4.98% | 1,623,906 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 10.36B | -0.84% | 1,652,111 | 105.82M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 10.22B | -2.24% | 1,803,788 | 3.24B |
| 25 | ABVX | ABIVAX Société Anonyme | 10.17B | 3.62% | 1,243,542 | 5.67M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.77B | 2.05% | 384,665 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.92B | 1.08% | 181,962 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.30B | 9.70% | 19,077,233 | 140.98M |
| 29 | NUVL | Nuvalent, Inc. | 8.29B | 2.77% | 425,595 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.15B | 0.59% | 2,031,599 | 1.51B |
| 31 | TECH | Bio-Techne Corporation | 7.51B | -0.50% | 2,588,200 | 1.21B |
| 32 | PCVX | Vaxcyte, Inc. | 7.24B | 5.94% | 1,318,214 | - |
| 33 | IMVT | Immunovant, Inc. | 6.95B | -0.94% | 1,883,177 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.64B | 2.38% | 503,076 | 51.48M |
| 35 | CELC | Celcuity Inc. | 6.55B | -2.87% | 687,490 | - |
| 36 | CORT | Corcept Therapeutics Incorporated | 6.48B | 0.23% | 681,816 | 769.10M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.43B | 0.80% | 360,762 | 74.06M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.40B | -0.54% | 478,893 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.21B | 2.03% | 443,886 | - |
| 40 | SRRK | Scholar Rock Holding Corporation | 6.17B | 7.02% | 2,654,664 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.16B | 2.25% | 322,665 | 217.17M |
| 42 | CNTA | Centessa Pharmaceuticals plc | 6.16B | 0.08% | 1,209,395 | 15.00M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.03B | 0.28% | 704,598 | 569.61M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.80B | 3.89% | 2,815,418 | - |
| 45 | TGTX | TG Therapeutics, Inc. | 5.63B | 2.21% | 1,291,538 | 700.35M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.61B | -1.69% | 1,003,611 | 827.11M |
| 47 | BLTE | Belite Bio, Inc | 5.59B | 3.43% | 309,211 | - |
| 48 | LEGN | Legend Biotech Corporation | 5.48B | 0.54% | 1,574,451 | 1.14B |
| 49 | CGON | CG Oncology, Inc. | 5.46B | -3.67% | 1,701,977 | 5.07M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.22B | -0.35% | 1,839,815 | 7.50M |
| 51 | CRSP | CRISPR Therapeutics AG | 4.98B | 2.44% | 1,454,909 | 4.10M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.75B | 0.39% | 377,714 | 1.34M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.72B | 2.62% | 222,324 | 274.48M |
| 54 | CAI | Caris Life Sciences, Inc. | 4.39B | -0.19% | 2,004,675 | 907.29M |
| 55 | MANE | Veradermics, Incorporated | 4.28B | 0.87% | 573,423 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.22B | 1.89% | 814,551 | 22.57M |
| 57 | TVTX | Travere Therapeutics, Inc. | 4.12B | -0.32% | 1,808,537 | 536.20M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | -0.05% | 716,518 | 18.07M |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.22% | 1,565,713 | 596.96M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | 0.76% | 964,969 | 1.10B |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 3.61B | 2.63% | 1,339,160 | - |
| 62 | ERAS | Erasca, Inc. | 3.58B | 2.31% | 3,186,753 | - |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.58B | -0.29% | 2,415,540 | - |
| 64 | ORKA | Oruka Therapeutics, Inc. | 3.56B | -2.56% | 1,212,379 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.30B | 1.06% | 99,499 | 803.79M |
| 66 | RLAY | Relay Therapeutics, Inc. | 3.09B | 4.73% | 2,373,696 | 10.68M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.08B | 3.97% | 2,354,219 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.03B | 2.99% | 1,110,099 | 236.00M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.00B | 4.49% | 1,686,112 | - |
| 70 | BEAM | Beam Therapeutics Inc. | 2.97B | 4.02% | 1,411,856 | 164.01M |
| 71 | TNGX | Tango Therapeutics, Inc. | 2.90B | -0.99% | 2,017,566 | 56.99M |
| 72 | ALMS | Alumis Inc. | 2.85B | 1.41% | 666,386 | 8.40M |
| 73 | GPCR | Structure Therapeutics Inc. | 2.81B | 1.00% | 398,894 | - |
| 74 | KLRA | Kailera Therapeutics, Inc. | 2.79B | 1.89% | 484,793 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.64B | 1.20% | 2,609,902 | 415.62M |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -1.77% | 1,068,574 | 535.08M |
| 77 | IRON | Disc Medicine, Inc. | 2.60B | 1.95% | 230,641 | - |
| 78 | ELVN | Enliven Therapeutics, Inc. | 2.59B | 2.38% | 538,926 | - |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.58B | 0.86% | 591,184 | 225.27M |
| 80 | DFTX | Definium Therapeutics, Inc. | 2.50B | 1.69% | 1,350,027 | - |
| 81 | IMNM | Immunome, Inc. | 2.48B | 1.15% | 1,094,623 | 4.02M |
| 82 | MLYS | Mineralys Therapeutics, Inc. | 2.47B | 0.47% | 937,628 | - |
| 83 | VERA | Vera Therapeutics, Inc. | 2.47B | 0.88% | 682,172 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.42B | 0.39% | 726,198 | 865.00K |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | -1.07% | 1,219,447 | 670.00M |
| 86 | KOD | Kodiak Sciences Inc. | 2.25B | -0.63% | 493,428 | - |
| 87 | NKTR | Nektar Therapeutics | 2.22B | -1.58% | 880,077 | 55.63M |
| 88 | NBTX | Nanobiotix S.A. | 2.08B | -0.51% | 70,730 | 38.27M |
| 89 | PHVS | Pharvaris N.V. | 2.08B | 0.67% | 191,721 | - |
| 90 | ZLAB | Zai Lab Limited | 2.07B | -0.86% | 557,143 | 453.28M |
| 91 | TRVI | Trevi Therapeutics, Inc. | 2.04B | 1.77% | 1,077,379 | - |
| 92 | TYRA | Tyra Biosciences, Inc. | 2.00B | 3.45% | 568,100 | - |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | -0.20% | 893,275 | 298.30M |
| 94 | SION | Sionna Therapeutics, Inc. | 1.94B | 4.25% | 188,816 | - |
| 95 | STOK | Stoke Therapeutics, Inc. | 1.93B | 5.76% | 478,418 | 32.08M |
| 96 | MESO | Mesoblast Limited | 1.90B | -1.97% | 122,186 | 65.38M |
| 97 | RAPP | Rapport Therapeutics, Inc. | 1.90B | 5.28% | 438,121 | 20.00M |
| 98 | ADMA | ADMA Biologics, Inc. | 1.89B | -1.09% | 3,357,678 | 509.86M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.88B | -1.39% | 1,488,673 | 70.92M |
| 100 | ZYME | Zymeworks Inc. | 1.85B | -0.82% | 1,001,884 | 81.26M |
| 101 | AAPG | Ascentage Pharma Group International | 1.85B | -4.20% | 6,275 | 82.08M |
| 102 | IOVA | Iovance Biotherapeutics, Inc. | 1.83B | -0.24% | 14,580,816 | 285.61M |
| 103 | LKFT | Lakefront Biotherapeutics NV | 1.83B | 0.65% | 69,614 | 1.20B |
| 104 | OCUL | Ocular Therapeutix, Inc. | 1.82B | 0.73% | 2,041,844 | 52.04M |
| 105 | NRIX | Nurix Therapeutics, Inc. | 1.80B | -0.69% | 1,029,544 | 71.78M |
| 106 | VCEL | Vericel Corporation | 1.79B | 0.69% | 465,457 | 292.09M |
| 107 | OCS | Oculis Holding AG | 1.77B | 1.49% | 273,597 | 1.40M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -0.20% | 850,098 | 217.17M |
| 109 | NTLA | Intellia Therapeutics, Inc. | 1.76B | 0.08% | 3,623,186 | 66.09M |
| 110 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -0.77% | 3,092,835 | 2.18B |
| 111 | HRMY | Harmony Biosciences Holdings, Inc. | 1.74B | -0.20% | 699,205 | 899.11M |
| 112 | NVAX | Novavax, Inc. | 1.72B | 13.57% | 8,324,001 | 596.34M |
| 113 | GENB | Generate Biomedicines, Inc. | 1.71B | -8.19% | 1,041,499 | 30.30M |
| 114 | CAPR | Capricor Therapeutics, Inc. | 1.70B | 1.70% | 674,651 | 11.13M |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.69B | 3.16% | 126,735 | - |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | 0.68% | 903,181 | 66.05M |
| 117 | ANAB | AnaptysBio, Inc. | 1.68B | -3.25% | 482,157 | 232.39M |
| 118 | INVA | Innoviva, Inc. | 1.67B | 0.98% | 901,782 | 420.69M |
| 119 | NUVB | Nuvation Bio Inc. | 1.63B | -0.64% | 2,719,658 | 143.05M |
| 120 | GLUE | Monte Rosa Therapeutics, Inc. | 1.62B | 2.07% | 697,547 | 42.95M |
| 121 | ABCL | AbCellera Biologics Inc. | 1.61B | 1.73% | 8,717,599 | 79.21M |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.61B | 1.82% | 2,729,531 | 7.47M |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.59B | 2.33% | 346,109 | - |
| 124 | GHRS | GH Research PLC | 1.59B | 4.66% | 340,940 | - |
| 125 | QURE | uniQure N.V. | 1.59B | 3.97% | 1,222,414 | 18.09M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.58B | 2.07% | 1,154,006 | 65.50M |
| 127 | RXRX | Recursion Pharmaceuticals, Inc. | 1.58B | -1.33% | 29,619,806 | 66.41M |
| 128 | ATAI | AtaiBeckley Inc. | 1.57B | -0.69% | 4,592,618 | 3.49M |
| 129 | INBX | Inhibrx Biosciences, Inc. | 1.57B | 5.46% | 228,829 | 1.30M |
| 130 | ARDX | Ardelyx, Inc. | 1.54B | 2.29% | 2,605,400 | 427.68M |
| 131 | BHVN | Biohaven Ltd. | 1.52B | 6.56% | 2,222,279 | - |
| 132 | PGEN | Precigen, Inc. | 1.51B | - | 6,099,107 | 31.60M |
| 133 | MBX | MBX Biosciences, Inc. | 1.51B | -0.31% | 247,656 | - |
| 134 | SLS | SELLAS Life Sciences Group, Inc. | 1.51B | 4.37% | 8,743,374 | - |
| 135 | IMTX | Immatics N.V. | 1.50B | -3.70% | 670,038 | 43.00M |
| 136 | IMCR | Immunocore Holdings plc | 1.50B | 2.01% | 385,633 | 412.81M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.46B | 2.21% | 495,105 | 20.00M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.44B | 1.38% | 555,042 | - |
| 139 | URGN | UroGen Pharma Ltd. | 1.44B | 1.97% | 611,170 | 140.49M |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.07% | 8,068,131 | 114.48M |
| 141 | SEPN | Septerna, Inc. | 1.38B | 8.06% | 347,396 | 72.26M |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.34B | 2.47% | 211,970 | - |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.33B | 0.22% | 575,313 | - |
| 144 | SVRA | Savara Inc. | 1.30B | 2.39% | 695,509 | - |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.30B | 4.53% | 552,294 | - |
| 146 | FTRE | Fortrea Holdings Inc. | 1.25B | - | 1,136,082 | 2.71B |
| 147 | COAG | Hemab Therapeutics Holdings, Inc. | 1.23B | 7.53% | 271,179 | - |
| 148 | WVE | Wave Life Sciences Ltd. | 1.23B | - | 2,457,584 | 71.80M |
| 149 | OLMA | Olema Pharmaceuticals, Inc. | 1.18B | -0.95% | 1,081,736 | - |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.18B | -1.27% | 407,734 | 10.00M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.14B | 1.18% | 166,089 | 8.28M |
| 152 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.13B | -0.45% | 5,118,784 | 204.73M |
| 153 | EYPT | EyePoint, Inc. | 1.12B | 3.25% | 918,191 | 7.61M |
| 154 | AVLN | Avalyn Pharma Inc. | 1.12B | -7.42% | 367,899 | - |
| 155 | DBVT | DBV Technologies S.A. | 1.11B | -0.11% | 175,219 | 5.74M |
| 156 | IVA | Inventiva S.A. | 1.10B | 1.78% | 127,282 | 7.94M |
| 157 | MNKD | MannKind Corporation | 1.09B | 4.44% | 3,704,851 | 360.78M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.08B | 1.74% | 844,135 | - |
| 159 | JBIO | Jade Biosciences, Inc. | 1.07B | -2.25% | 606,403 | - |
| 160 | PHAR | Pharming Group N.V. | 973.18M | 8.10% | 31,406 | 369.49M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 955.03M | 2.91% | 181,098 | - |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 950.14M | 11.71% | 964,780 | - |
| 163 | DRTS | Alpha Tau Medical Ltd. | 935.13M | 3.29% | 796,507 | - |
| 164 | KURA | Kura Oncology, Inc. | 924.14M | -7.47% | 2,932,514 | 71.64M |
| 165 | ABUS | Arbutus Biopharma Corporation | 916.57M | 6.67% | 2,327,238 | 191.45M |
| 166 | LXRX | Lexicon Pharmaceuticals, Inc. | 914.85M | -4.63% | 3,074,558 | 69.64M |
| 167 | ANNX | Annexon, Inc. | 904.41M | 3.95% | 4,504,766 | - |
| 168 | MGTX | MeiraGTx Holdings plc | 889.05M | 3.90% | 619,283 | 79.76M |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 884.04M | 2.64% | 913,811 | - |
| 170 | PHAT | Phathom Pharmaceuticals, Inc. | 881.67M | -2.03% | 834,488 | 204.89M |
| 171 | JANX | Janux Therapeutics, Inc. | 878.17M | -0.83% | 365,204 | 13.73M |
| 172 | XNCR | Xencor, Inc. | 862.27M | 2.83% | 526,296 | 97.36M |
| 173 | SANA | Sana Biotechnology, Inc. | 848.79M | -0.65% | 4,075,545 | - |
| 174 | TBPH | Theravance Biopharma, Inc. | 845.98M | 0.24% | 434,113 | 109.78M |
| 175 | OMER | Omeros Corporation | 843.17M | 1.66% | 1,170,484 | 9.89M |
| 176 | AVTX | Avalo Therapeutics, Inc. | 842.10M | -2.02% | 1,381,387 | 59.00K |
| 177 | EVMN | Evommune, Inc. | 841.03M | 2.10% | 392,871 | 10.00M |
| 178 | AURA | Aura Biosciences, Inc. | 839.38M | 0.13% | 276,838 | - |
| 179 | DRUG | Bright Minds Biosciences Inc. | 828.73M | 3.33% | 199,104 | - |
| 180 | ODTX | Odyssey Therapeutics, Inc. | 828.38M | 0.34% | 400,111 | 2.98M |
| 181 | ABSI | Absci Corporation | 823.18M | 3.53% | 3,048,614 | 1.84M |
| 182 | GERN | Geron Corporation | 821.15M | - | 10,873,596 | 196.12M |
| 183 | LBRX | LB Pharmaceuticals Inc | 812.41M | 0.75% | 128,957 | - |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 811.31M | 2.90% | 1,060,977 | 98.99M |
| 185 | CTMX | CytomX Therapeutics, Inc. | 803.32M | -1.86% | 2,542,552 | 35.54M |
| 186 | VOR | Vor Biopharma Inc. | 764.02M | -1.61% | 685,987 | - |
| 187 | RLMD | Relmada Therapeutics, Inc. | 752.05M | 1.85% | 726,375 | - |
| 188 | ANRO | Alto Neuroscience, Inc. | 738.21M | -0.75% | 413,618 | - |
| 189 | ALLO | Allogene Therapeutics, Inc. | 731.73M | 6.00% | 4,770,341 | 22.00K |
| 190 | DSGN | Design Therapeutics, Inc. | 712.01M | 3.92% | 1,035,825 | - |
| 191 | TENX | Tenax Therapeutics, Inc. | 705.36M | -1.24% | 353,003 | - |
| 192 | SGP | SpyGlass Pharma, Inc. | 689.26M | -1.06% | 86,575 | - |
| 193 | SLDB | Solid Biosciences Inc. | 677.33M | 3.93% | 790,771 | - |
| 194 | CBIO | Crescent Biopharma, Inc. | 676.21M | -1.88% | 326,381 | 11.88M |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 670.50M | -2.11% | 416,463 | - |
| 196 | CRMD | CorMedix Inc. | 648.80M | 3.63% | 1,313,577 | 400.05M |
| 197 | ACRS | Aclaris Therapeutics, Inc. | 629.88M | -0.22% | 718,192 | 8.37M |
| 198 | IMMX | Immix Biopharma, Inc. | 616.95M | 0.68% | 3,651,400 | - |
| 199 | ZVRA | Zevra Therapeutics, Inc. | 610.07M | 2.89% | 1,853,522 | 122.29M |
| 200 | CABA | Cabaletta Bio, Inc. | 606.56M | 1.92% | 2,415,531 | - |
| 201 | TRAX | First Tracks Biotherapeutics, Inc. | 595.09M | -0.73% | 290,822 | - |
| 202 | CADL | Candel Therapeutics, Inc. | 582.50M | -0.50% | 1,320,174 | - |
| 203 | ARVN | Arvinas, Inc. | 575.53M | -1.87% | 636,575 | 89.40M |
| 204 | ALT | Altimmune, Inc. | 569.81M | 1.03% | 2,154,110 | 36.00K |
| 205 | DNA | Ginkgo Bioworks Holdings, Inc. | 567.67M | 3.33% | 954,229 | 151.40M |
| 206 | VALN | Valneva SE | 567.60M | 2.02% | 21,941 | 180.25M |
| 207 | TECX | Tectonic Therapeutic, Inc. | 565.89M | 2.99% | 367,462 | - |
| 208 | ASMB | Assembly Biosciences, Inc. | 553.47M | 1.45% | 244,658 | 71.10M |
| 209 | MDXG | MiMedx Group, Inc. | 546.63M | 1.38% | 2,192,202 | 389.42M |
| 210 | AGMB | AgomAb Therapeutics NV | 544.19M | -3.91% | 87,435 | - |
| 211 | CLYM | Climb Bio, Inc. | 544.08M | 3.55% | 676,541 | - |
| 212 | GYRE | Gyre Therapeutics, Inc. | 542.75M | -1.98% | 125,949 | 117.05M |
| 213 | RIGL | Rigel Pharmaceuticals, Inc. | 539.71M | 0.55% | 441,641 | 299.77M |
| 214 | PRME | Prime Medicine, Inc. | 536.43M | - | 2,332,390 | 4.03M |
| 215 | FBRX | Forte Biosciences, Inc. | 536.12M | 1.62% | 205,052 | - |
| 216 | EIKN | Eikon Therapeutics, Inc. | 535.97M | -9.26% | 402,427 | - |
| 217 | PRTA | Prothena Corporation plc | 526.67M | 2.34% | 918,666 | 57.94M |
| 218 | XOMA | XOMA Royalty Corporation | 523.21M | 0.17% | 67,599 | 48.56M |
| 219 | KYTX | Kyverna Therapeutics, Inc. | 521.17M | -0.69% | 981,955 | - |
| 220 | CTNM | Contineum Therapeutics, Inc. | 512.19M | -1.15% | 209,883 | - |
| 221 | PROK | ProKidney Corp. | 510.48M | -3.43% | 896,542 | 889.00K |
| 222 | EPRX | Eupraxia Pharmaceuticals Inc. | 488.65M | 6.06% | 360,491 | - |
| 223 | STTK | Shattuck Labs, Inc. | 468.52M | 0.16% | 440,091 | 1.00M |
| 224 | ACHV | Achieve Life Sciences, Inc. | 468.13M | -2.77% | 1,039,781 | - |
| 225 | FDMT | 4D Molecular Therapeutics, Inc. | 455.33M | 1.28% | 393,064 | 88.24M |
| 226 | ANL | Adlai Nortye Ltd. | 454.00M | -4.78% | 61,666 | 5.00M |
| 227 | STRO | Sutro Biopharma, Inc. | 453.63M | 7.08% | 643,045 | 99.61M |
| 228 | OCGN | Ocugen, Inc. | 453.62M | - | 5,568,075 | 4.47M |
| 229 | FULC | Fulcrum Therapeutics, Inc. | 450.44M | 2.89% | 375,124 | 80.00M |
| 230 | AUTL | Autolus Therapeutics plc | 447.12M | -1.18% | 1,071,336 | 92.62M |
| 231 | UPB | Upstream Bio, Inc. | 446.79M | -1.91% | 593,003 | 3.32M |
| 232 | ADCT | ADC Therapeutics SA | 446.44M | 3.54% | 793,909 | 79.18M |
| 233 | SGMT | Sagimet Biosciences Inc. | 445.85M | 1.83% | 909,660 | - |
| 234 | NGNE | Neurogene Inc. | 428.23M | -2.20% | 156,113 | 925.00K |
| 235 | OVID | Ovid Therapeutics Inc. | 423.94M | -0.81% | 1,096,281 | 7.12M |
| 236 | MNPR | Monopar Therapeutics Inc. | 419.48M | -0.79% | 165,443 | - |
| 237 | VTVT | vTv Therapeutics Inc. | 411.50M | -3.63% | 58,208 | 36.84M |
| 238 | PRLD | Prelude Therapeutics Incorporated | 411.36M | -4.22% | 311,103 | 16.72M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 403.60M | 0.59% | 601,570 | - |
| 240 | IFRX | InflaRx N.V. | 403.58M | 4.98% | 1,644,815 | 33.82K |
| 241 | ZURA | Zura Bio Limited | 399.45M | -3.44% | 490,409 | - |
| 242 | CMPX | Compass Therapeutics, Inc. | 396.19M | 6.28% | 4,729,744 | 850.00K |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 393.43M | -3.01% | 330,510 | 69.21M |
| 244 | BNTC | Benitec Biopharma Inc. | 393.36M | 1.96% | 93,045 | - |
| 245 | IPSC | Century Therapeutics, Inc. | 391.37M | -3.98% | 728,886 | 109.16M |
| 246 | CCCC | C4 Therapeutics, Inc. | 384.53M | -1.97% | 1,679,000 | 34.86M |
| 247 | VSTM | Verastem, Inc. | 383.13M | 2.83% | 1,737,848 | 49.59M |
| 248 | LYEL | Lyell Immunopharma, Inc. | 381.98M | -6.24% | 134,045 | 31.00K |
| 249 | REPL | Replimune Group, Inc. | 379.83M | -6.31% | 3,602,303 | - |
| 250 | GLSI | Greenwich LifeSciences, Inc. | 379.48M | -0.94% | 99,325 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 377.28M | -0.99% | 287,726 | 9.01M |
| 252 | VNDA | Vanda Pharmaceuticals Inc. | 374.04M | 0.48% | 888,573 | 217.78M |
| 253 | ARTV | Artiva Biotherapeutics, Inc. | 372.67M | -2.54% | 312,376 | 251.00K |
| 254 | PBYI | Puma Biotechnology, Inc. | 370.04M | 2.68% | 223,928 | 227.18M |
| 255 | OABI | OmniAb, Inc. | 369.68M | -3.77% | 831,420 | 28.94M |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 362.52M | 2.49% | 323,214 | - |
| 257 | LRMR | Larimar Therapeutics, Inc. | 362.21M | 0.58% | 921,001 | - |
| 258 | RZLT | Rezolute, Inc. | 344.74M | 1.54% | 900,111 | - |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 343.55M | -0.40% | 135,699 | 51.00M |
| 260 | IMRX | Immuneering Corporation | 340.96M | -2.23% | 2,084,027 | - |
| 261 | DMAC | DiaMedica Therapeutics Inc. | 340.54M | 6.94% | 182,703 | - |
| 262 | NMRA | Neumora Therapeutics, Inc. | 336.15M | -0.54% | 1,292,978 | - |
| 263 | PALI | Palisade Bio, Inc. | 333.17M | 2.05% | 2,578,399 | - |
| 264 | RCKT | Rocket Pharmaceuticals, Inc. | 327.58M | 1.35% | 1,980,386 | - |
| 265 | RGNX | REGENXBIO Inc. | 326.21M | -0.63% | 1,421,433 | 87.82M |
| 266 | IVVD | Invivyd, Inc. | 324.07M | - | 2,222,102 | 55.87M |
| 267 | LCTX | Lineage Cell Therapeutics, Inc. | 321.59M | -0.77% | 1,233,741 | 14.78M |
| 268 | BCYC | Bicycle Therapeutics plc | 319.04M | 0.44% | 148,568 | 63.50M |
| 269 | SLN | Silence Therapeutics plc | 313.64M | 7.10% | 217,399 | 839.00K |
| 270 | ABEO | Abeona Therapeutics Inc. | 312.90M | 0.92% | 577,320 | 14.54M |
| 271 | NAUT | Nautilus Biotechnology, Inc. | 308.80M | -4.33% | 387,496 | - |
| 272 | NAGE | Niagen Bioscience, Inc. | 308.07M | 5.46% | 1,398,331 | 130.42M |
| 273 | SRZN | Surrozen, Inc. | 303.84M | -0.76% | 50,599 | 7.49M |
| 274 | YDES | YD Bio Limited | 303.08M | -9.26% | 8,233 | 510.36K |
| 275 | EDIT | Editas Medicine, Inc. | 301.55M | 11.59% | 9,667,398 | 38.69M |
| 276 | ELDN | Eledon Pharmaceuticals, Inc. | 300.71M | - | 1,419,217 | - |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 299.80M | -2.27% | 55,643 | 5.20M |
| 278 | IRD | Opus Genetics, Inc. | 292.04M | -3.99% | 795,349 | 11.98M |
| 279 | ACIU | AC Immune SA | 290.66M | 3.53% | 311,745 | 4.62M |
| 280 | IKT | Inhibikase Therapeutics, Inc. | 289.72M | 0.59% | 413,780 | 1.00 |
| 281 | MGNX | MacroGenics, Inc. | 284.11M | -1.32% | 1,052,611 | 157.08M |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 281.90M | -2.46% | 650,801 | 26.87M |
| 283 | CLLS | Cellectis S.A. | 269.89M | 4.86% | 22,501 | 75.11M |
| 284 | TARA | Protara Therapeutics, Inc. | 269.78M | -2.44% | 828,957 | - |
| 285 | NVCT | Nuvectis Pharma, Inc. | 267.91M | -2.42% | 128,730 | - |
| 286 | SABS | SAB Biotherapeutics, Inc. | 267.75M | -2.31% | 447,428 | 114.70K |
| 287 | ALXO | ALX Oncology Holdings Inc. | 259.70M | -2.53% | 2,096,534 | - |
| 288 | FHTX | Foghorn Therapeutics Inc. | 256.58M | 3.55% | 282,913 | 28.22M |
| 289 | CHRS | Coherus Oncology, Inc. | 252.97M | 1.86% | 1,268,869 | 46.88M |
| 290 | AVXL | Anavex Life Sciences Corp. | 251.14M | 0.56% | 924,437 | - |
| 291 | CGEN | Compugen Ltd. | 250.65M | -5.36% | 418,079 | 72.66M |
| 292 | FATE | Fate Therapeutics, Inc. | 250.60M | -4.44% | 5,573,110 | 6.32M |
| 293 | HUMA | Humacyte, Inc. | 246.44M | 5.71% | 7,120,931 | 2.02M |
| 294 | ADAG | Adagene Inc. | 245.79M | -0.80% | 325,849 | 7.67M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 243.54M | -2.91% | 79,983 | 19.39M |
| 296 | NERV | Minerva Neurosciences, Inc. | 243.19M | -0.76% | 175,316 | - |
| 297 | ALEC | Alector, Inc. | 243.15M | -0.90% | 480,570 | 18.42M |
| 298 | LENZ | LENZ Therapeutics, Inc. | 243.00M | 2.65% | 709,789 | 20.99M |
| 299 | CNTX | Context Therapeutics Inc. | 241.64M | 1.15% | 833,066 | - |
| 300 | TRDA | Entrada Therapeutics, Inc. | 241.42M | 2.13% | 513,533 | 5.74M |
| 301 | OBIO | Orchestra BioMed Holdings, Inc. | 237.73M | -2.22% | 351,617 | 32.72M |
| 302 | CDXS | Codexis, Inc. | 236.33M | 4.42% | 584,184 | 78.09M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 235.77M | 6.24% | 1,013,973 | 7.15M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 231.41M | 0.79% | 404,673 | 36.49M |
| 305 | NGEN | NervGen Pharma Corp. | 226.21M | 2.40% | 5,791,345 | - |
| 306 | RNA | Atrium Therapeutics, Inc. | 223.40M | -0.23% | 170,909 | 36.68M |
| 307 | KROS | Keros Therapeutics, Inc. | 222.26M | 0.36% | 480,475 | 33.18M |
| 308 | HELP | Cybin Inc. | 221.66M | -5.34% | 639,759 | - |
| 309 | NKTX | Nkarta, Inc. | 218.93M | 0.99% | 461,586 | - |
| 310 | NBP | NovaBridge Biosciences | 215.11M | 5.08% | 713,716 | - |
| 311 | MDWD | MediWound Ltd. | 214.38M | 0.60% | 84,873 | 14.48M |
| 312 | CAMP | Camp4 Therapeutics Corporation | 212.90M | -9.09% | 113,140 | 3.93M |
| 313 | CRBU | Caribou Biosciences, Inc. | 212.24M | 2.86% | 1,947,062 | 11.20M |
| 314 | ARCT | Arcturus Therapeutics Holdings Inc. | 204.93M | 2.56% | 334,556 | 54.71M |
| 315 | TNXP | Tonix Pharmaceuticals Holding Corp. | 203.56M | - | 595,548 | 17.56M |
| 316 | KPTI | Karyopharm Therapeutics Inc. | 202.28M | 9.93% | 570,693 | 151.12M |
| 317 | DTIL | Precision BioSciences, Inc. | 195.58M | 4.84% | 494,832 | 45.07M |
| 318 | TLSA | Tiziana Life Sciences Ltd | 192.71M | 2.03% | 192,035 | - |
| 319 | MIST | Milestone Pharmaceuticals Inc. | 190.47M | -0.71% | 1,269,133 | 1.78M |
| 320 | RNAC | Cartesian Therapeutics, Inc. | 189.51M | -4.44% | 374,231 | 1.78M |
| 321 | UNCY | Unicycive Therapeutics, Inc. | 188.50M | -12.62% | 1,642,628 | - |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 186.40M | -6.53% | 383,057 | - |
| 323 | ELTX | Elicio Therapeutics, Inc. | 184.51M | 0.80% | 143,150 | - |
| 324 | GALT | Galectin Therapeutics Inc. | 183.74M | 11.60% | 987,612 | - |
| 325 | KRRO | Korro Bio, Inc. | 177.83M | 6.20% | 107,325 | 3.84M |
| 326 | IMUX | Immunic, Inc. | 176.67M | -0.61% | 247,991 | - |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 174.79M | -3.59% | 306,350 | - |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 172.42M | 1.90% | 734,789 | 76.38M |
| 329 | ANTX | AN2 Therapeutics, Inc. | 170.26M | -2.47% | 535,879 | - |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 169.69M | 1.23% | 2,622,936 | 225.00K |
| 331 | IPHA | Innate Pharma S.A. | 168.97M | -6.01% | 40,351 | 10.57M |
| 332 | HRTX | Heron Therapeutics, Inc. | 167.19M | 2.85% | 1,607,284 | 150.71M |
| 333 | OKUR | OnKure Therapeutics, Inc. | 166.43M | -2.14% | 202,809 | - |
| 334 | SPRO | Spero Therapeutics, Inc. | 165.60M | 3.62% | 1,516,806 | 61.19M |
| 335 | PRQR | ProQR Therapeutics N.V. | 165.42M | 0.64% | 440,643 | 15.73M |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 165.34M | 1.25% | 312,943 | 2.00M |
| 337 | ENLV | Enlivex Ltd. | 164.88M | -4.67% | 594,143 | - |
| 338 | MENS | Jyong Biotech Ltd. | 161.09M | 0.93% | 57,972 | - |
| 339 | TTRX | Turn Therapeutics Inc. | 159.66M | 4.48% | 58,486 | - |
| 340 | HURA | TuHURA Biosciences, Inc. | 156.02M | -2.00% | 519,335 | - |
| 341 | NRXP | NRx Pharmaceuticals, Inc. | 156.01M | 33.85% | 4,342,036 | 2.29M |
| 342 | EQ | Equillium, Inc. | 146.69M | 2.65% | 269,987 | 4.39M |
| 343 | MOLN | Molecular Partners AG | 146.63M | -3.11% | 4,569 | 856.30K |
| 344 | GUTS | Fractyl Health, Inc. | 145.61M | 0.90% | 1,715,992 | 3.00K |
| 345 | KZIA | Kazia Therapeutics Limited | 142.95M | -8.42% | 253,373 | 1.27M |
| 346 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 140.30M | -30.31% | 3,749,469 | - |
| 347 | SPRB | Spruce Biosciences, Inc. | 140.01M | 1.43% | 50,390 | 697.00K |
| 348 | AGEN | Agenus Inc. | 137.91M | 6.75% | 703,044 | 123.87M |
| 349 | CNTB | Connect Biopharma Holdings Limited | 135.65M | 2.13% | 507,713 | 233.00K |
| 350 | GNLX | Genelux Corporation | 133.67M | 3.08% | 114,245 | 8.00K |
| 351 | BDTX | Black Diamond Therapeutics, Inc. | 133.51M | 2.19% | 2,684,361 | 70.00M |
| 352 | CRDF | Cardiff Oncology, Inc. | 132.64M | 8.99% | 1,832,207 | 525.00K |
| 353 | NTHI | NeOnc Technologies Holdings, Inc. | 130.13M | -3.75% | 12,332 | 39.99K |
| 354 | ACOG | Alpha Cognition Inc. | 128.03M | 0.51% | 16,537 | 10.83M |
| 355 | INDP | Indaptus Therapeutics, Inc. | 125.70M | -9.02% | 65,689 | - |
| 356 | PLYX | Polaryx Therapeutics, Inc. | 122.15M | -28.33% | 1,227,776 | - |
| 357 | ALPS | Alps Group Inc | 121.24M | 8.20% | 17,760 | 3.74M |
| 358 | QTTB | Q32 Bio Inc. | 120.22M | 22.24% | 299,527 | 53.74M |
| 359 | KLRS | Kalaris Therapeutics, Inc. | 119.79M | 5.89% | 156,115 | - |
| 360 | ENGN | enGene Therapeutics Inc. | 117.90M | 7.32% | 1,969,391 | - |
| 361 | CGTX | Cognition Therapeutics, Inc. | 110.80M | -1.59% | 838,138 | - |
| 362 | COYA | Coya Therapeutics, Inc. | 110.48M | -2.08% | 93,115 | 7.94M |
| 363 | CBUS | Cibus, Inc. | 109.08M | 3.62% | 294,296 | 4.29M |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 107.37M | 14.84% | 1,975,914 | - |
| 365 | VANI | Vivani Medical, Inc. | 106.93M | 3.33% | 223,552 | - |
| 366 | PEPG | PepGen Inc. | 105.83M | 1.32% | 501,579 | - |
| 367 | SEER | Seer, Inc. | 105.51M | 4.47% | 234,975 | 15.17M |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 103.42M | -0.66% | 25,535 | 37.16M |
| 369 | PYXS | Pyxis Oncology, Inc. | 103.27M | -16.84% | 1,277,970 | 13.86M |
| 370 | INO | Inovio Pharmaceuticals, Inc. | 103.24M | -6.67% | 2,142,632 | 65.34K |
| 371 | BMEA | Biomea Fusion, Inc. | 101.94M | -0.70% | 1,404,379 | - |
| 372 | RNTX | Rein Therapeutics Inc. | 99.55M | 3.88% | 349,721 | - |
| 373 | ICCC | ImmuCell Corporation | 94.99M | 3.75% | 66,687 | 29.93M |
| 374 | PTHS | Pelthos Therapeutics Inc. | 94.43M | 1.91% | 10,644 | 27.70M |
| 375 | ONCY | Oncolytics Biotech Inc. | 94.10M | 0.10% | 496,061 | - |
| 376 | RANI | Rani Therapeutics Holdings, Inc. | 93.87M | -12.10% | 1,946,049 | 3.17M |
| 377 | PMN | ProMIS Neurosciences, Inc. | 92.91M | -5.65% | 33,834 | - |
| 378 | PYPD | PolyPid Ltd. | 92.36M | -3.59% | 148,963 | - |
| 379 | AARD | Aardvark Therapeutics, Inc. | 91.63M | -7.49% | 216,308 | - |
| 380 | ANIX | Anixa Biosciences, Inc. | 91.53M | -2.15% | 104,633 | - |
| 381 | LONA | LeonaBio, Inc. | 90.84M | -6.39% | 88,641 | - |
| 382 | OKYO | OKYO Pharma Limited | 89.74M | 4.91% | 125,366 | - |
| 383 | FBIO | Fortress Biotech, Inc. | 89.36M | -1.82% | 469,469 | 66.16M |
| 384 | ANVS | Annovis Bio, Inc. | 87.64M | -7.62% | 1,537,440 | - |
| 385 | ACET | Adicet Bio, Inc. | 87.47M | 0.36% | 90,236 | - |
| 386 | EDSA | Edesa Biotech, Inc. | 86.19M | -7.27% | 240,958 | - |
| 387 | EXOZ | eXoZymes, Inc. | 84.03M | -0.10% | 1,232 | -700.00 |
| 388 | CSBR | Champions Oncology, Inc. | 83.11M | -0.42% | 6,275 | 57.95M |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 81.80M | -1.94% | 182,561 | 23.14M |
| 390 | HYFT | MindWalk Holdings Corp. | 80.96M | -4.68% | 782,912 | 20.70M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 80.87M | 3.91% | 526,781 | - |
| 392 | NRXS | NeurAxis, Inc. | 80.54M | -5.15% | 119,260 | 4.28M |
| 393 | OSTX | OS Therapies Incorporated | 77.94M | 1.16% | 449,169 | - |
| 394 | RLYB | Rallybio Corporation | 77.76M | -7.43% | 36,346 | 858.00K |
| 395 | GANX | Gain Therapeutics, Inc. | 77.63M | 2.25% | 1,158,324 | - |
| 396 | PLRX | Pliant Therapeutics, Inc. | 76.78M | 2.48% | 703,875 | - |
| 397 | MCRB | Seres Therapeutics, Inc. | 73.50M | -4.17% | 45,297 | 1.15M |
| 398 | XBIT | XBiotech Inc. | 73.17M | -1.23% | 19,980 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 71.48M | -4.57% | 245,909 | - |
| 400 | ATHE | Alterity Therapeutics Limited | 70.10M | -1.45% | 23,723 | 4.43M |
| 401 | TCRX | TScan Therapeutics, Inc. | 69.93M | 0.94% | 535,146 | 9.14M |
| 402 | FLNA | Filana Therapeutics, Inc. | 68.11M | 7.63% | 707,274 | - |
| 403 | MNOV | MediciNova, Inc. | 67.43M | -2.14% | 34,080 | 596.64K |
| 404 | IBIO | iBio, Inc. | 65.78M | -1.09% | 1,105,669 | 300.00K |
| 405 | IMA | ImageneBio, Inc. | 65.64M | 4.68% | 22,060 | 800.00K |
| 406 | LIXT | Lixte Biotechnology Holdings, Inc. | 65.64M | -3.91% | 153,378 | - |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 65.60M | -2.38% | 248,770 | - |
| 408 | CUE | Cue Biopharma, Inc. | 65.20M | -6.71% | 72,692 | 32.73M |
| 409 | CING | Cingulate Inc. | 63.46M | 6.94% | 865,707 | - |
| 410 | BYSI | BeyondSpring Inc. | 63.32M | -1.91% | 33,326 | 1.88M |
| 411 | PDSB | PDS Biotechnology Corporation | 61.40M | -8.33% | 988,427 | - |
| 412 | ENTX | Entera Bio Ltd. | 59.56M | -2.42% | 30,144 | 42.00K |
| 413 | DWTX | Dogwood Therapeutics, Inc. | 59.45M | -0.56% | 84,121 | - |
| 414 | IMMP | Immutep Limited | 59.11M | -6.63% | 943,280 | 5.28M |
| 415 | IBO | Impact BioMedical Inc. | 55.20M | -5.85% | 33,691 | 39.00K |
| 416 | TIL | Instil Bio, Inc. | 55.07M | -0.73% | 26,941 | - |
| 417 | MREO | Mereo BioPharma Group plc | 53.26M | 19.91% | 22,878,515 | 500.00K |
| 418 | ACTU | Actuate Therapeutics, Inc. | 52.64M | -7.56% | 155,472 | - |
| 419 | HYPD | Hyperion DeFi, Inc. | 52.56M | 2.21% | 601,366 | 1.04M |
| 420 | INKT | MiNK Therapeutics, Inc. | 52.01M | -3.96% | 16,638 | - |
| 421 | GOSS | Gossamer Bio, Inc. | 51.63M | 4.71% | 13,230,272 | 55.54M |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 51.20M | 0.74% | 162,161 | 22.33M |
| 423 | RADX | Radiopharm Theranostics Limited | 50.77M | -0.43% | 16,311 | 10.86M |
| 424 | XLO | Xilio Therapeutics, Inc. | 49.96M | 1.21% | 22,658 | 53.48M |
| 425 | ESLA | Estrella Immunopharma, Inc. | 49.49M | -0.86% | 58,006 | - |
| 426 | OTLK | Outlook Therapeutics, Inc. | 48.37M | 29.14% | 346,266,296 | 333.14K |
| 427 | ATYR | aTyr Pharma, Inc. | 47.49M | -1.16% | 2,282,447 | 190.00K |
| 428 | QNTM | Quantum BioPharma Ltd. | 45.41M | -23.70% | 1,788,038 | - |
| 429 | PSTV | Plus Therapeutics, Inc. | 45.29M | 0.15% | 103,550 | 5.18M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 44.35M | - | 77,985 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 42.63M | -0.20% | 30,311 | - |
| 432 | NTRB | Nutriband Inc. | 42.36M | -4.26% | 25,111 | 2.04M |
| 433 | RNXT | RenovoRx, Inc. | 41.26M | 3.89% | 433,765 | 1.49M |
| 434 | KALA | KALA BIO, Inc. | 40.34M | -10.70% | 134,195 | - |
| 435 | INMB | INmune Bio Inc. | 38.02M | -1.38% | 241,102 | 50.00K |
| 436 | LTRN | Lantern Pharma Inc. | 37.89M | -3.43% | 224,586 | - |
| 437 | VERU | Veru Inc. | 37.08M | -1.70% | 97,494 | 16.89M |
| 438 | GRCE | Grace Therapeutics, Inc. | 36.52M | 7.27% | 525,806 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 36.16M | -1.69% | 79,225 | 90.00K |
| 440 | TVGN | Tevogen Bio Holdings Inc. | 36.01M | -10.51% | 19,083 | - |
| 441 | LITS | Lite Strategy, Inc. | 35.73M | -1.87% | 857,294 | - |
| 442 | ALGS | Aligos Therapeutics, Inc. | 35.52M | -0.35% | 79,411 | 4.71M |
| 443 | DARE | Daré Bioscience, Inc. | 35.05M | -1.27% | 233,754 | 1.16M |
| 444 | NNVC | NanoViricides, Inc. | 34.40M | -7.93% | 1,154,375 | - |
| 445 | EVAX | Evaxion A/S | 34.28M | 0.74% | 18,397 | 7.53M |
| 446 | BOLD | Boundless Bio, Inc. | 32.95M | 2.08% | 79,342 | - |
| 447 | ABVC | ABVC BioPharma, Inc. | 32.60M | 13.16% | 204,416 | 797.92K |
| 448 | TVRD | Tvardi Therapeutics, Inc. | 32.27M | -3.64% | 55,690 | - |
| 449 | APLM | Apollomics, Inc. | 30.94M | - | 1,302 | 8.84M |
| 450 | SNTI | Senti Biosciences Holdings, Inc. | 30.90M | 0.54% | 262,008 | 38.00K |
| 451 | NRSN | NeuroSense Therapeutics Ltd. | 30.82M | 6.33% | 110,082 | - |
| 452 | PLRZ | Polyrizon Ltd. | 30.08M | 5.31% | 36,560 | - |
| 453 | NEUP | Neuphoria Therapeutics Inc. | 29.52M | -0.33% | 23,804 | -13.27K |
| 454 | LSTA | Lisata Therapeutics, Inc. | 28.90M | 1.91% | 69,508 | 170.00K |
| 455 | SKYE | Skye Bioscience, Inc. | 28.88M | -0.87% | 134,594 | - |
| 456 | SER | Serina Therapeutics, Inc. | 28.61M | -3.03% | 98,696 | 130.00K |
| 457 | GRDX | GridAI Technologies Corp. | 28.58M | -4.75% | 129,123 | - |
| 458 | CRVO | CervoMed Inc. | 28.24M | -0.33% | 114,775 | 2.09M |
| 459 | IGC | IGC Pharma, Inc. | 28.18M | -0.97% | 321,731 | 1.11M |
| 460 | BRNS | Barinthus Biotherapeutics plc | 27.84M | -0.79% | 21,045 | 14.97M |
| 461 | KYNB | Kyntra Bio, Inc. | 27.73M | -2.00% | 5,962 | 7.44M |
| 462 | DYAI | Dyadic International, Inc. | 27.51M | -0.55% | 104,498 | 3.81M |
| 463 | ALLR | Allarity Therapeutics, Inc. | 26.05M | -4.80% | 318,967 | 345.00K |
| 464 | CELU | Celularity Inc. | 25.96M | 3.08% | 139,734 | 26.55M |
| 465 | JSPR | Jasper Therapeutics, Inc. | 25.55M | 1.06% | 114,555 | - |
| 466 | TPST | Tempest Therapeutics, Inc. | 25.39M | -4.84% | 115,235 | - |
| 467 | NXTC | NextCure, Inc. | 25.33M | -10.34% | 86,843 | - |
| 468 | VTGN | Vistagen Therapeutics, Inc. | 25.23M | -1.59% | 287,825 | 789.00K |
| 469 | PLUR | Pluri Inc. | 24.92M | -2.70% | 14,164 | 1.08M |
| 470 | BCTX | BriaCell Therapeutics Corp. | 24.83M | -2.01% | 188,417 | - |
| 471 | PTN | Palatin Technologies, Inc. | 24.81M | -2.92% | 12,388 | 12.88M |
| 472 | CLRB | Cellectar Biosciences, Inc. | 24.77M | -3.13% | 187,194 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.18M | 3.57% | 64,703 | 3.55M |
| 474 | TRAW | Traws Pharma, Inc. | 23.94M | 6.04% | 573,665 | 2.73M |
| 475 | LGVN | Longeveron Inc. | 23.75M | -1.12% | 507,429 | 1.22M |
| 476 | KTTA | Pasithea Therapeutics Corp. | 22.73M | -2.82% | 168,180 | - |
| 477 | VYNE | VYNE Therapeutics Inc. | 22.64M | 1.21% | 122,480 | 454.00K |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 22.51M | 4.40% | 798,679 | 1.14M |
| 479 | SNSE | Sensei Biotherapeutics, Inc. | 22.10M | -7.42% | 27,181 | - |
| 480 | CVM | CEL-SCI Corporation | 20.72M | 0.70% | 233,338 | - |
| 481 | AKTX | Akari Therapeutics, Plc | 20.39M | -2.52% | 2,536,624 | - |
| 482 | AEON | AEON Biopharma, Inc. | 20.26M | -0.93% | 62,167 | - |
| 483 | CRIS | Curis, Inc. | 19.76M | -1.40% | 135,744 | 7.06M |
| 484 | QNCX | Quince Therapeutics, Inc. | 19.56M | 9.09% | 1,799,703 | - |
| 485 | CTXR | Citius Pharmaceuticals, Inc. | 19.13M | -0.58% | 544,931 | 5.61M |
| 486 | HCWB | HCW Biologics Inc. | 18.76M | -9.34% | 3,025,965 | 6.59M |
| 487 | LPCN | Lipocine Inc. | 18.14M | - | 152,496 | 2.00M |
| 488 | PASG | Passage Bio, Inc. | 17.80M | 6.12% | 21,259 | - |
| 489 | XCUR | Exicure, Inc. | 17.04M | -4.85% | 6,283 | 500.00K |
| 490 | NCEL | NewcelX Ltd. | 16.96M | -0.32% | 13,688 | - |
| 491 | INAB | IN8bio, Inc. | 16.64M | 1.20% | 55,470 | - |
| 492 | LEXX | Lexaria Bioscience Corp. | 16.49M | 2.37% | 125,018 | 368.00K |
| 493 | PHGE | BiomX Inc. | 16.44M | 98.41% | 69,944,661 | - |
| 494 | OSRH | OSR Holdings, Inc. | 16.40M | -1.39% | 719,226 | 2.63M |
| 495 | HIND | Vyome Holdings, Inc. | 16.21M | 3.59% | 32,735 | 152.72K |
| 496 | CVKD | Cadrenal Therapeutics, Inc. | 15.98M | - | 72,363 | - |
| 497 | COCP | Cocrystal Pharma, Inc. | 15.58M | -1.74% | 350,562 | 225.00K |
| 498 | MLEC | Moolec Science SA | 15.46M | -4.38% | 11,801 | 7.83M |
| 499 | MTVA | MetaVia Inc. | 15.34M | -22.86% | 3,375,497 | - |
| 500 | CMMB | Chemomab Therapeutics Ltd. | 14.62M | 0.50% | 56,117 | - |